Mirador Capital Partners LP Eli Lilly & CO Transaction History

Mirador Capital Partners LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	BUY	$592.2 - $792.28 $905,473 - $1.21 Million	1,529 New	1,529 $1.19 Million
Q2 2021 Jul 27, 2021	SELL	$180.55 - $233.54 $2.88 Million - $3.72 Million	-15,930 Closed	0 $0
Q1 2021 Apr 29, 2021	BUY	$164.32 - $212.72 $2.62 Million - $3.39 Million	15,930 New	15,930 $2.98 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $930,035 - $1.16 Million	-10,832 Closed	0 $0
Q2 2018 Aug 08, 2018	SELL	$75.7 - $86.88 $45,722 - $52,475	-604 Reduced 5.28%	10,832 $924,000
Q1 2018 May 02, 2018	SELL	$74.21 - $87.6 $107,901 - $127,370	-1,454 Reduced 11.28%	11,436 $927,000
Q4 2017 Feb 12, 2018	BUY	$81.94 - $87.89 $33,841 - $36,298	413 Added 3.31%	12,890 $1.09 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $15,182 - $16,851	197 Added 1.6%	12,477 $1.08 Million
Q2 2017 Aug 08, 2017	BUY	N/A	12,280	12,280 $1.01 Million

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Mirador Capital Partners LP, based on Form 13F filings with the SEC.

Stay updated on Mirador Capital Partners LP with notifications on news.